Recommended
Recommended
More Related Content
Similar to Supporting Chemical Pharmaceutical Industry
Similar to Supporting Chemical Pharmaceutical Industry (20)
More from Monica Mazzoni
More from Monica Mazzoni (20)
Recently uploaded
Recently uploaded (20)
Supporting Chemical Pharmaceutical Industry
- 1. 3DS.COM/BIOVIA©DassaultSystèmes|ConfidentialInformation|6/18/2020|ref.:3DS_Document_2016 Dassault Systemes BIOVIA Supporting Chemical Pharmaceutical Industry Emmanuele Puricelli, Sales Expert emmanuele.puricelli@3ds.com Mobile: +39 342 5722105 and Domenico Palumberi, Industry Consultant 18 June 2020
- 2. 3DS.COM/BIOVIA©DassaultSystèmes|ConfidentialInformation|6/18/2020|ref.:3DS_Document_2016 a Scientific company Combining Science, Technology and Art for a sustainable society 20,000 passionate people • 130 nationalities • 181 sites • One global R&D / 64 labs 270,000 customers • 11 industries in 140 countries • 25 million users • Game-changing 3DEXPERIENCE solutions 12,600 partners • Software, Technology & Architecture • Content & Online Services • Sales • Consulting & System Integrators (C&SI) • Education • Research Long-term driven • Majority shareholder control • Revenue: €4,055 million* • Operating margin: 32%* * Figures as of FY 2019 / Non-IFRS
- 4. 3DS.COM/BIOVIA©DassaultSystèmes|ConfidentialInformation|6/18/2020|ref.:3DS_Document_2016 Collaborative Science Unified Lab Management Process Production Operations Quality and Regulatory Predictive Models Engineered Materials Chemicals & FormulationsNovel Therapeutics
- 5. 3DS.COM/BIOVIA©DassaultSystèmes|ConfidentialInformation|6/18/2020|ref.:3DS_Document_2016 Challenges for the Pharmaceutical Lab 1 2 3 4 5 6 7 Dark Data Inefficient Processes Tech Transfer Doing More With Less Compliance Burden Lack of Consistency Hindered Collaboration
- 6. 3DS.COM/BIOVIA©DassaultSystèmes|ConfidentialInformation|6/18/2020|ref.:3DS_Document_2016 Challenges for the Pharmaceutical Lab 1 2 3 4 5 6 7 Dark Data Inefficient Processes Tech Transfer Doing More With Less Compliance Burden Lack of Consistency Hindered Collaboration
- 7. 3DS.COM/BIOVIA©DassaultSystèmes|ConfidentialInformation|6/18/2020|ref.:3DS_Document_2016 Technology Advance – Moving to a Digital Lab Before After
- 8. 3DS.COM/BIOVIA©DassaultSystèmes|ConfidentialInformation|6/18/2020|ref.:3DS_Document_2016 ONE Lab Optimize Your Laboratories and Leverage Knowledge to Improve Time to Market Batch Release Biologics Process Development Develop biologics drug products and processes for manufacturing and characterization using industry standard S88 process model. Drug Product Development Design & develop drug product formulas and compositions for target efficacy, safety, cost performance, and scalability. Analytical Development Develop and validate analytical methods to analyze in-process, finished product, and stability samples in a validatable end-to-end environment. Schedule and document raw material, finished product, in process quality control testing workflows and outcomes with a compliance-ready solution. Small Molecule Process Development Design drug substance chemical reaction processes for target quality, safety, cost performance, and scalability. .
- 9. 3DS.COM/BIOVIA©DassaultSystèmes|ConfidentialInformation|6/18/2020|ref.:3DS_Document_2016 ONE Lab – The Laboratory Workflow • • • • • • • • • • • ONE Lab
- 12. 3DS.COM/BIOVIA©DassaultSystèmes|ConfidentialInformation|6/18/2020|ref.:3DS_Document_2016 Biological and Chemical Inventory Inventory Material and Container Management Integration with vendor catalogs Search for substances across inventory and vendors catalogs Safety & Regulations Swift reporting for international, national and local agencies Multilingual, jurisdictional, versioned GHS/OSHA SDS Safety enforcement through warnings and alerts Management Stock thresholds monitoring Storage restrictions & Access control Locations (sites, buildings, labs, etc…) management
- 13. 3DS.COM/BIOVIA©DassaultSystèmes|ConfidentialInformation|6/18/2020|ref.:3DS_Document_2016 Inventory Biological and Chemical Inventory
- 16. 3DS.COM/BIOVIA©DassaultSystèmes|ConfidentialInformation|6/18/2020|ref.:3DS_Document_2016 Manage and author standard procedures BIOVIA eBR Method Development
- 17. 3DS.COM/BIOVIA©DassaultSystèmes|ConfidentialInformation|6/18/2020|ref.:3DS_Document_2016 Execute error-free procedures BIOVIA eBR Method Execution
- 18. 3DS.COM/BIOVIA©DassaultSystèmes|ConfidentialInformation|6/18/2020|ref.:3DS_Document_2016 Capture – Mobile Recipe and Method Execution • Execute recipes & methods authored in Compose • Enforce limits and tolerances • Observe Cautions & Notes • Record observations
- 21. 3DS.COM/BIOVIA©DassaultSystèmes|ConfidentialInformation|6/18/2020|ref.:3DS_Document_2016 Designed for mobility BIOVIA Lab Services enables other BIOVIA applications to acquire data through web services, allowing users to be mobile throughout their workflow ADF